loader image
Friday, December 19, 2025
75.4 F
McAllen
- Advertisement -

A Safer Blood Thinner? 

This novel blood clot treatment doesn't increase bleeding risk

Health & Lifestyle
202

Listen to article (english)

Translate to Spanish or other 102 languages!

Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes
Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes

Medical News Today

- Advertisement -
  • While anticoagulants are important for preventing dangerous blood clots, they increase the risk of excessive bleeding.
  • Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound.
  • Rather than target all clotting pathways to prevent thrombosis, the new compound strategically targets just one, so clotting continues but without a bleeding risk or toxicity.

Anticoagulants, or blood thinners, break down and prevent blood clots, semi-solid clumps of blood cells, and other substances that can block blood flow. However, anticoagulants can do their job too well, preventing clotting altogether and resulting in excessive external or internal bleeding.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/blood-thinner-potential-blood-clot-treatment-lower-bleeding-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-02&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Hispanic People – Especially Men – Are Less Likely to See a Doctor
Next article
Why Young Women Have More Adverse Outcomes After a Heart Attack Than Young Men

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×